Angiotech Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - MarketLine Financial Deals

Angiotech Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Angiotech Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - MarketLine Financial Deals
Angiotech Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Published Oct 10, 2016
56 pages — Published Oct 10, 2016
Price US$ 350.00  |  Buy this Report Now

About This Report

  
Abstract:

Project Synopsis:

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

Marketlines' Angiotech Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Angiotech Pharmaceuticals, Inc. since January 2007.

Scope:

- Provides intelligence on Angiotech Pharmaceuticals, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Angiotech Pharmaceuticals, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Angiotech Pharmaceuticals, Inc.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Highlights:

This report includes Angiotech Pharmaceuticals, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Angiotech Pharmaceuticals, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Angiotech Pharmaceuticals, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors' business structure and growth strategies.

  
Source:
Document ID
178D262F-7C50-48E8-BFBF-10C5EB4F5E68
Industry
Ticker
ANPI.OQ=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
TABLE OF CONTENTS
COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions - Overview
--Mergers and Acquisitions - Deal reports
--Corporate Venturing - Deal reports
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
DIVESTMENTS
--Divestments - Overview
--Divestments - Deal reports
APPENDIX
--About Datamonitor Financial Deals Database
--Deal Definition and Methodology
--About Datamonitor
--Datamonitor Professional Services Knowledge Center
LIST OF TABLES
--Angiotech Pharmaceuticals activity by deal type - volume (trailing twelve months (TTM))
--Angiotech Pharmaceuticals M&A activity by geography (TTM)
--Angiotech Pharmaceuticals activity by deal type - volume (2012 -YTD2016)
--Angiotech Pharmaceuticals M&A average deal size - value ($m) (2012 -YTD2016)
--Angiotech Pharmaceuticals legal advisor ranking by value ($m)
--Angiotech Pharmaceuticals financial advisor ranking by value ($m)
--Top Deals(2012 -YTD2016)
--Angiotech Pharmaceuticals targets and partners (2012 -YTD2016)
--Angiotech Pharmaceuticals M&A volume and value trend (2012-YTD2016)
--Angiotech Pharmaceuticals M&A activity by geography (2012-YTD2016)
--Angiotech Pharmaceuticals partnership volume and value trend (2012-YTD2016)
--Angiotech Pharmaceuticals partnership trend by key deal type (2012-YTD2016)
--Angiotech Pharmaceuticals divestments volume and value trend (2012-YTD2016)
--Angiotech Pharmaceuticals divestments activity by geography (2012-YTD2016)
LIST OF FIGURES
--Angiotech Pharmaceuticals activity by deal type - volume (trailing twelve months (TTM))
--Angiotech Pharmaceuticals M&A activity by geography (TTM)
--Angiotech Pharmaceuticals activity by deal type - volume (2012-YTD2016)
--Angiotech Pharmaceuticals M&A average deal size - value ($m)
--Angiotech Pharmaceuticals M&A volume and value trend (2012-YTD2016)
--Angiotech Pharmaceuticals M&A activity by geography (2012-YTD2016)
--Angiotech Pharmaceuticals partnership volume and value trend (2012-YTD2016)
--Angiotech Pharmaceuticals partnership trend by key deal type (2012-YTD2016)
--Angiotech Pharmaceuticals divestments volume and value trend (2012-YTD2016)

Table Of Contents

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Angiotech Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report" Oct 10, 2016. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Angiotech-Pharmaceuticals-Inc-Mergers-Acquisitions-M-A-Partnerships-Alliances-and-Investment-Report-2052-52841>
  
APA:
MarketLine Financial Deals. (2016). Angiotech Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Oct 10, 2016. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Angiotech-Pharmaceuticals-Inc-Mergers-Acquisitions-M-A-Partnerships-Alliances-and-Investment-Report-2052-52841>
  
US$ 350.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.